Patent Assignment
Reel/Frame 020360/0234
Assignment of Assignor's Interest
Recorded: 2008-01-14
Pages: 27
Assignor
VALEANT PHARMACEUTICALS NORTH AMERICA
Executed: 2008-01-14
Assignee
THREE RIVERS PHARMACEUTICALS, LLC
301 COMMERCE PARK DRIVE, CRANBERRY TOWNSHIP, PENNSYLVANIA, 16066
Covered Properties
(18)
Method for treating hepatitis c virus infection in treatment failure patients
Application:
10/490,456 →
Publication:
US 2005/0031585
Method of treating hepatitis virus infection with a multiphasic interferon delivery profile
Application:
10/490,458 →
Publication:
US 2005/0063949
Combination therapy for treating alphavirus infection and liver fibrosis
Application:
10/545,864 →
Publication:
US 2007/0072181
Continuous delivery methods for treating hepatitis virus infection
Application:
10/545,867 →
Publication:
US 2007/0077225
Compositions and methods for treating poxvirus infection
Application:
10/551,368 →
Publication:
US 2007/0154454
Combination Therapy for Treating Hepatitis C Virus Infection
Application:
10/584,169 →
Publication:
US 2007/0258946
Compositions and methods for treating coronavirus infection and SARS
Application:
10/814,701 →
Publication:
US 2005/0002901
Combination therapy for treating hepatitis C virus infection
Application:
11/579,962 →
Method for treating hepatitis C virus infection in treatment failure patients
Application:
60/326,088 →
Method for treating hepatitis C virus infection in treatment failure patients
Application:
60/326,100 →
Method of treating hepatitis virus infection with multiphasic interferon delivery profile
Application:
60/327,744 →
Combination therapy for treating flavivirus infection and liver fibrosis
Application:
60/451,316 →
Continuous delivery methods for treating hepatitis virus infection
Application:
60/451,349 →
Compositions and methods for treating poxvirus infection
Application:
60/458,916 →
Compositions and methods for treating coronavirus infection and SARS
Application:
60/459,783 →
Combination therapy for treating hepatitis C virus infection
Application:
60/532,834 →
Combination therapy for treating hepatitis virus infection
Application:
60/571,196 →
Combination therapy for the treatment of non-alcoholic steatohepatitis and alcoholic liver disease
Application:
60/571,227 →
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 31, 2002
From: HSU, HENRY H.
To: INTERMUNE PHARMACEUTICALS, INC.
Reel/Frame 013214/0395 →
Assignment of Assignor's Interest
Oct 31, 2002
From: HENRY, HSU II
To: INTERMUNE PHARMACEUTICALS, INC.
Reel/Frame 013214/0375 →
Assignment of Assignor's Interest
Oct 31, 2002
From: HUS, HENRY IL
To: INTERMUNE PHARMACEUTICALS, INC.
Reel/Frame 013214/0348 →
Assignment of Assignor's Interest
Nov 14, 2002
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 013242/0354 →
Assignment of Assignor's Interest
Jan 28, 2004
From: BLATT, LAWRENCE M; MURPHY, BRIAN
To: INTERMUNE, INC.
Reel/Frame 014295/0657 →
Assignment of Assignor's Interest
Feb 19, 2004
From: BLATT, LAWRENCE M
To: INTERMUNE, INC
Reel/Frame 014347/0474 →
Change of Name
Mar 19, 2004
From: INTERMUNE PHARMACEUTICALS INC.
To: INTERMUNE INC.
Reel/Frame 014447/0622 →
Assignment of Assignor's Interest
Apr 2, 2004
From: BLATT, LAWRENCE M
To: INTERMUNE, INC.
Reel/Frame 014472/0542 →
Assignment of Assignor's Interest
Apr 21, 2004
From: VISOR, GARY; VAN VLASSELAER, PETER
To: INTERMUNE, INC.
Reel/Frame 014518/0959 →
Assignment of Assignor's Interest
Aug 4, 2004
From: BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 014945/0336 →
Assignment of Assignor's Interest
Aug 20, 2004
From: BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 015016/0630 →
Assignment of Assignor's Interest
Aug 20, 2004
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 015920/0904 →
Assignment of Assignor's Interest
Sep 30, 2004
From: VISOR, GARY; VAN VLASSELAER, PETER
To: INTERMUNE, INC.
Reel/Frame 016040/0597 →
Assignment of Assignor's Interest
Oct 11, 2004
From: OZES, OSMAN N.; SEIWERT, SCOTT D.; BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 015241/0184 →
Assignment of Assignor's Interest
Oct 12, 2004
From: OZES, OSMAN N.; SEIWERT, SCOTT D.; BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 015241/0433 →
Corrective Assignment to Correct the Filing Date of Application Number 10490456 Previously Recorded on Reel 015920 Frame 0904. Assignor(S) Hereby Confirms the Correct Filing Date Is 08/20/2004.
Jul 20, 2005
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 016287/0579 →
Assignment of Assignor's Interest
Feb 1, 2006
From: INTERMUNE, INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 017224/0910 →
Assignment of Assignor's Interest
Jun 12, 2006
From: BLATT, LAWRENCE M.; MURPHY, BRIAN M.
To: INTERMUNE, INC.
Reel/Frame 017764/0276 →
Assignment of Assignor's Interest
Dec 6, 2006
From: INTERMUNE INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 018614/0270 →
Assignment of Assignor's Interest
Dec 6, 2006
From: INTERMUNE INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 018608/0846 →
Assignment of Assignor's Interest
Jun 4, 2007
From: BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 019373/0588 →
Security Agreement
Jan 15, 2008
From: THREE RIVERS PHARMACEUTICALS, LLC; THREE RIVERS RESEARCH INSTITUTE 1, LLC; 3RP INVESTMENT CORPORATION; THREE RIVERS BIOLOGICS, LLC
To: NATIONAL CITY BANK
Reel/Frame 020362/0787 →
Release of Security Interest
Jul 15, 2010
From: PNC BANK, NATIONAL ASSOCIATION
To: THREE RIVERS PHARMACEUTICALS, LLC; THREE RIVERS RESEARCH INSTITUTE I, LLC; 3RP INVESTMENT CORPORATION; THREE RIVERS BIOLOGICS, LLC
Reel/Frame 024686/0764 →
Security Agreement
Nov 23, 2011
From: KADMON PHARMACEUTICALS, LLC
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 027280/0954 →